Prescription medication · Fifth-Generation Cephalosporin
ceftaroline
Also sold as Teflaro. This medicine treats acute bacterial skin infections in adults and children.
Data updated 2026-05-15
- Rx
- Availability
ceftaroline (Teflaro) is a prescription Fifth-Generation Cephalosporin. This medicine treats acute bacterial skin infections in adults and children.
Ceftaroline (Teflaro) is an antibiotic medicine. It fights bacterial infections in the skin, skin structures, and lungs.
Verify with FDA → · CMS NADAC pricing →
What it does
This medicine treats acute bacterial skin infections in adults and children.
Common side effects
Diarrhea, Nausea, Rash
Key warnings
You should not take this medicine if you are seriously allergic to ceftaroline or other cephalosporin antibiotics.
The sections below are summarized in plain English from ceftaroline's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Ceftaroline belongs to a class of antibiotics called cephalosporins. It works by stopping the growth of bacteria. This helps your body fight off the infection.
Serious Warnings
You should not take this medicine if you are seriously allergic to ceftaroline or other cephalosporin antibiotics. Ceftaroline can cause severe allergic reactions. Tell your doctor if you have diarrhea, as it could be a sign of a Clostridioides difficile infection. Ceftaroline may also cause neurological problems. This medicine can also affect the results of a blood test called the Coombs test, and may cause anemia.
Common Questions
What kind of drug is ceftaroline?
How is ceftaroline given?
How often will I receive ceftaroline?
How long does the infusion take?
What should I do if I experience diarrhea while taking ceftaroline?
Can ceftaroline cause an allergic reaction?
Can I take ceftaroline if I'm allergic to penicillin?
Will ceftaroline interact with other medications I'm taking?
Can ceftaroline affect my kidneys?
Is ceftaroline safe for children?
What are the common side effects of ceftaroline?
What drug class is ceftaroline?
What pregnancy or breastfeeding source fields are listed for ceftaroline?
Related Medications in Fifth-Generation Cephalosporin
Other drugs grouped near ceftaroline - same-class peers and common alternatives.
amikacin
Amikin
Amikacin is an antibiotic medicine.
Compare with ceftaroline →
amoxicillin
Amoxil
Amoxicillin and Clavulanate Potassium is a combination medicine used to fight bacterial infections.
Compare with ceftaroline →
amoxicillin/clavulanate
Augmentin
Augmentin is a combination of two medicines, amoxicillin and clavulanate.
Compare with ceftaroline →
ampicillin/sulbactam
Unasyn
Unasyn is a combination of two antibiotics that fights bacteria in your body.
Compare with ceftaroline →
azithromycin
Zithromax, Z-Pack
Azithromycin is an antibiotic that fights bacteria.
Compare with ceftaroline →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on ceftaroline
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for ceftaroline
The FDA label for ceftaroline (sold under brand names such as Teflaro) classifies it as a prescription-only medication in the Fifth-Generation Cephalosporin class. This medicine treats acute bacterial skin infections in adults and children. Official labeling lists 5 commonly reported side effects, including Diarrhea, Nausea, Rash.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. Interaction data is drawn directly from FDA-approved prescribing information. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: February 3, 2026
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages